Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectProtein Expression: Global Markets
The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.
Biological Therapies for Cancer: Technologies and Global Markets
The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.
Fusion Proteins: Global Market
The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.
Separation Systems for Commercial Biotechnology
The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.
Biomarker Deals: Terms Value and Trends 2019-2025
This report provides an analysis of strategic transactions encompassing licensing, acquisitions and collaborations in the global biomarker market. It focuses on deals executed between 2019 and 2025, providing a retrospective assessment of deal-making activity to identify emerging trends, investment behaviors and strategic priorities in the biomarker landscape.
mRNA: Therapeutics and Global Markets
The global market for mRNA therapeutics was valued at $7.71 billion in 2025 and is forecast to remain stable or slightly decline to $7.69 billion by the end of 2030, at a compound annual growth rate (CAGR) of -0.04% during the forecast period of 2025 to 2030.
The Chinese Market for DNA Sequencing
The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.
Molecular Diagnostics: Technologies and Global Markets
The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.
Global Biotechnology Equipment Market
The global market for biotechnology equipment was valued at $87.8 billion in 2024 and is estimated to increase from $95.1 billion in 2025 to reach $143.9 billion by 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 through 2030.
Chromatography in Pharmaceuticals and Biotechnology: Global Marke...
The global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
Genome Editing: Technologies and Global Markets
The global market for genome editing is expected to grow from $10.8 billion in 2025 and is projected to reach $23.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.9% during the forecast period of 2025 to 2030.
Global Assisted Reproductive Technologies Market
The report provides an analysis of the global assisted reproductive technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented into procedure, product, end user, and region. The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape.
Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Th...
The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.
Global DNA Forensics Market
The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.
Global Blood Platelet Market
The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.
Digital Biomarkers: Global Markets
The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.
Whole Genome Sequencing: Global Markets
The global market for whole genome sequencing is expected to grow from $3 billion in 2025 and forecast to reach $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing
The report provides an overview of the global genetic modification therapies market and analyzes market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
Validation Calibration and Standardization in the Life Sciences Market
This report provides an overview of global Validation, Calibration, and Standardization in Life Sciences Market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.
Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
This report provides an analysis of cloud computing for cell biology, genomics and drug design along with detailed profiles of key market players including a revenue product portfolio and recent activities. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030.
Cell and Gene Therapy Tools and Reagents: Global Markets
This report provides an overview of the global cell and gene therapy tools and reagents market. This report also examines strategies and collaborations, and macroeconomic factors.
Oligonucleotides: Global Markets
This report provides an overview of the global oligonucleotides market and analyzes market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
This report provides an overview of the global stem cell and regenerative medicine market. It covers market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030. The report also includes emerging technologies, ESG developments, and profiles of the key companies.
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
This study provides a comprehensive analysis of CNS biomarkers globally. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, to quantify and qualify the global CNS biomarkers market.
Botanical and Plant-derived Drugs: Global Markets
The report provides an overview of the global market for botanical and plant derived drugs and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.
Mesotherapy: Global Markets
The report provides an overview of the global mesotherapy market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030
